GlaxoSmithKline’s board of directors announced today that it terminated Moncef Slaoui as the chair of the Galvani board of directors. Slaoui previously served as the head of Operation Warp Speed — the Trump administration’s program to accelerate COVID-19 vaccine development. He was terminated effective immediately, according to a news release from GSK, the majority shareholder […]
galvanibioelectronics
EnteroMedics inks deal with Verily-GSK JV Galvani Bioelectronics
EnteroMedics (NSDQ:ETRM) said today it inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline (NYSE:GSK) and Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, through which Galvani will use a modified vBloc system for pre-clinical research. St. Paul, Minn.-based said it will receive payments for its development under the agreement, and that it will retain rights, title and […]